Abstract

Abstract C-reactive protein (CRP), an ancient host-defense plasma protein, is produced by hepatocytes. In Hep3B cells, CRP expression is induced by IL-6; IL-1β synergistically enhances the IL-6 effect. A critical regulatory segment on the CRP promoter contains binding sites for transcription factors C/EBPβ (-48 to -57) and NF-κB (-63 to -74). The κB site overlaps an octamer motif (-59 to -66) which is the binding site for the constitutively expressed transcription factor OCT-1. OCT-1 is known to function both as a transcriptional repressor and activator depending upon the promoter context. The aim of this study was to investigate the function of OCT-1 on the CRP promoter. In luciferase transactivation assays, overexpressed OCT-1 inhibited cytokine-induced CRP expression. EMSA, mutational analysis of the κB site, and the OCT-1 dose-response assays suggested that OCT-1 and NF-κB compete for binding to their overlapping cognate sites. Deletion of the OCT-1 site drastically reduced the cytokine response because the κB site was altered as a consequence of deleting the OCT-1 site. Surprisingly, overexpressed OCT-1 inhibited the residual cytokine-induced CRP expression through the promoter lacking the OCT-1 site. OCT-1 also inhibited overexpressed C/EBPβ-induced CRP expression. We conclude that OCT-1 acts as a repressor of CRP gene expression and it does so by occupying its cognate site on the promoter and also via other transcription factors by an as yet undefined mechanism.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.